Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rui‑Li Cai"'
Autor:
Xun‑Zhou Liu, Li Yin, Hong‑Juan Cui, Shi‑Cang Yu, Rui‑Li Cai, Xiaowei Qi, Li Chen, Ze‑Yu Yang
Publikováno v:
Oncology Letters
Triple-negative breast cancer (TNBC) has a greater risk of recurrence and metastasis along with a worse prognosis compared with other subtypes of breast cancer. Studies have revealed that mitogenic estrogen signaling is involved in the malignant prol
Autor:
Lu, Chen, Mian-Fu, Cao, Jing-Fang, Xiao, Qing-Hua, Ma, Han, Zhang, Rui-Li, Cai, Jing-Ya, Miao, Wen-Ying, Wang, Hua, Zhang, Min, Luo, Yi-Fang, Ping, Xiao-Hong, Yao, You-Hong, Cui, Xia, Zhang, Xiu-Wu, Bian
Publikováno v:
Human pathology. 97
Immunotherapies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand (PD-L1) axis have been emerging as a promising therapeutic strategy to treat lung cancer. PD-1 is preferentially expressed by activated T lymphocytes; but whether/how its ex
Autor:
Ting Zhang, Rui-Li Cai, Jing-Ya Miao, Cui Xiang, Qing-Qiu Chen, Yong-Jun Yang, Yao Li, Shi-Cang Yu, Ling Zhong, Fan Zhang
Publikováno v:
Clinical breast cancer. 19(5)
Background Neoadjuvant chemotherapy (NAC) is widely administered in the primary treatment of triple-negative breast cancer (TNBC). However, serum biomarkers for evaluating or monitoring the curative efficacy of NAC have not been established. Accumula
Autor:
LI YIN, XIAO-WEI QI, XUN-ZHOU LIU, ZE-YU YANG, RUI-LI CAI, HONG-JUAN CUI, LI CHEN, SHI-CANG YU
Publikováno v:
Oncology Letters; Jun2020, Vol. 19 Issue 6, p3950-3958, 9p
Autor:
Yao Li, Xiang Cui, Yong-Jun Yang, Qing-Qiu Chen, Ling Zhong, Ting Zhang, Rui-Li Cai, Jing-Ya Miao, Shi-Cang Yu, Fan Zhang, Li, Yao, Cui, Xiang, Yang, Yong-Jun, Chen, Qing-Qiu, Zhong, Ling, Zhang, Ting, Cai, Rui-Li, Miao, Jing-Ya, Yu, Shi-Cang, Zhang, Fan
Publikováno v:
Clinical Breast Cancer; Oct2019, Vol. 19 Issue 5, p326-332, 7p